Overview and transparency of non-research payments to healthcare organizations and healthcare professionals from pharmaceutical companies in Japan: Analysis of payment data in 2016Akihiko Ozaki, Tetsuya Tanimoto, Hiroaki Saito et al.|Health Policy|2020Cited by 59
Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in JapanHiroaki Saito, Tetsuya Tanimoto, Akihiko Ozaki et al.|JAMA Network Open|2019Cited by 57
Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in JapanAnju Murayama, Tetsuya Tanimoto, Akihiko Ozaki et al.|PLoS ONE|2020Cited by 45
Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysisAkihiko Ozaki, Tetsuya Tanimoto, Yosuke Onoue et al.|BMJ Open|2019Cited by 44
Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice GuidelineAnju Murayama, Akihiko Ozaki, Kohki Yamada et al.|Clinical Journal of the American Society of Nephrology|2022Cited by 40